+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

Calcium Channel Blockers - Global Strategic Business Report - Product Thumbnail Image

Calcium Channel Blockers - Global Strategic Business Report

  • Report
  • November 2024
  • 93 Pages
  • Global
From
Anti-Platelet Agents - Global Strategic Business Report - Product Thumbnail Image

Anti-Platelet Agents - Global Strategic Business Report

  • Report
  • November 2024
  • 94 Pages
  • Global
From
Anti-Ischemic Agents - Global Strategic Business Report - Product Thumbnail Image

Anti-Ischemic Agents - Global Strategic Business Report

  • Report
  • November 2024
  • 94 Pages
  • Global
From
Fondaparinux - Global Strategic Business Report - Product Thumbnail Image

Fondaparinux - Global Strategic Business Report

  • Report
  • November 2024
  • 93 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
Aplastic Anemia Market Report 2024 - Product Thumbnail Image

Aplastic Anemia Market Report 2024

  • Report
  • September 2024
  • 175 Pages
  • Global
From
Coronary Artery Disease Global Market Report 2024 - Product Thumbnail Image

Coronary Artery Disease Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Angina Global Market Report 2024 - Product Thumbnail Image

Angina Global Market Report 2024

  • Report
  • August 2024
  • 175 Pages
  • Global
From
Phosphodiesterase (PDE) Inhibitors Market 2024-2028 - Product Thumbnail Image

Phosphodiesterase (PDE) Inhibitors Market 2024-2028

  • Report
  • December 2023
  • 165 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more